Curriculum Vitae Dennis F. Moore, Jr., Md, Facp
Total Page:16
File Type:pdf, Size:1020Kb
CURRICULUM VITAE DENNIS F. MOORE, JR., M.D., F.A.C.P. Office Address: 818 N. Emporia, Ste, 403 Wichita, KS 67214 Office Phone: (316) 262-4467 / Fax: (316) 262-0706 Present Position: Physician, Cancer Center of Kansas Date of Hire: 07/01/94 Medical Licensure: 1990, State of Kansas EDUCATION Year Degree Institution 8/1979-5/1982 -- Washington University, St. Louis, Missouri 8/1982-5/1983 B.A. University of Kansas, Lawrence, Kansas 8/1983-5/1987 M.D. University of Kansas School of Medicine, Kansas City, Kansas POSTGRADUATE EDUCATION: Year Degree Institution 1987-90 Resident, Internal Medicine Baylor College of Medicine, Houston, Texas 1990-93 Fellow, Medical Oncology University of Texas, M.D. Anderson Cancer Center and Hematology, Houston, Texas 7-12/1991 Fellow, Hematology Baylor College of Medicine, Houston, Texas ACADEMIC APPOINTMENTS: Month & Year Position Institution 7/1/04 Clinical Professor of Medicine University of Kansas School of Medicine Wichita, Kansas 7/1/99 Clinical Associate Professor University of Kansas School of Medicine Wichita, Kansas 7/1996 to 6/1998 Clinical Assistant Professor University of Kansas School of Medicine Wichita, Kansas 7/1994 to 6/1996 Assistant Professor University of Kansas School of Medicine Wichita, Kansas 7/1994 Adjunct Assistant Professor University of Texas, M.D. Anderson Cancer of Medicine Center, Houston, Texas 7/1993 to 6/1994 Assistant Professor & University of Texas, M.D. Anderson Cancer Assistant Internist Center, Houston, Texas 11/1991 to 6/1993 Junior Faculty Associate University of Texas, M.D. Anderson Cancer Center, Houston, Texas Dennis F. Moore, Jr. Curriculum Vitae – Page 2 CERTIFICATION: Board Date Recertification American Board of Internal Medicine 9/1991 11/2001 Subspecialty (ABIM) Medical Oncology 11/1993 11/2001 Subspecialty (ABIM) Hematology 11/1996 PROFESSIONAL SOCIETIES AND AFFILIATIONS: (INCLUDING OFFICES HELD) Year Organization Office 2019 Cancer Research of Kansas Participating Physician 2014 Medical Society of Sedgwick County Membership & Ethics Committee 2009-10 Wesley Medical Center Internal Medicine Exec. Committee 2006 Kansas Chapter of American Society of Clinical Oncology President 2004 Journal of Rheumatology Reviewer 1999 American College of Physicians Fellow American Society of Internal Medicine Texas Society of Internal Medicine American Society of Hematology American Society of Clinical Oncology American Society for Blood and Marrow Transplantation Kansas Society of Clinical Oncology 1997 International Society for Hematotherapy and Graft Engineering Secretary 1994 National Cancer Institute (NCI) M.D. Anderson University of Rochester National Surgical Adjuvant Breast & Bowel Project (NSABP) Wichita Community Clinical Oncology Program (WCCOP) Board Member Leukemia Society of America (Kansas Chapter) Southwest Oncology Group (SWOG) HONORS AND AWARDS: Year Organization 2011 Platinum Award for ≥ 25 Patients in total accruals in NCI/Cancer Control Clinical Trials 2012 Plaque received for 2nd highest enrollment of patients on NCI Treatment and Cancer Control Clinical Trials (WCCOP Award). Washington University, St. Louis, Missouri 1981-82 President, Xi Chapter of Tau Kappa Epsilon 1983-87 University of Kansas School of Medicine Summer Research Fellowship Nell Educational Trust Scholarship 1987 Cieneguilla, Peru St. Francis Award, Parroquia de Cieneguilla Dennis F. Moore, Jr. Curriculum Vitae – Page 3 American Cancer Society 1990-91 Junior Investigator Award 1992-93 Research Fellowship University of Texas, M.D. Anderson Cancer Center 1990-91 Clifton D. Howe Award for Excellence in Clinical Oncology 1991-92 Competitive Research Award 1991-92 Sandoz Research Fellow Award (Dept. Hematology) 1992-93 Competitive Research Award 6/9/1993 Outstanding Chief Fellow (Special Award) Schwachmann Syndrome Foundation and Registry 4/1995- Advisory Board Leukemia Society of America 8/1997 Dr. Dennis Moore, Sr. Award 2/2001- Preferred Health Systems Specialty Advisory Board 5/2004 Clinical Professor – KU School of Medicine 4/2004 Loyal Order of the Moose 9/2005 Via Christi Regional Medical Center St. Luke Physician Recognition Award for the core value of Human Dignity RESEARCH ACTIVITIES: 1. Brief statement of area of research interest: a. Lymphoma, hematologic malignancies and stem cell transplantation 2. Current Projects Underway: a. Completing work on lymphoma booklet b. Analyzing and writing manuscript for Phase II Lymphoma Trial for SWOG c. Collaborating with colleagues at MD Anderson Cancer Center to complete manuscripts regarding original observations in patients with lymphoma. 3. Grant Support Available: a. Previous grants b. American Cancer Society (1990-91, $10,000) c. Competitive Research Award, University of Texas MD Anderson Cancer Center: 1991-92, $3,300. d. Sandoz Research Fellow Award: 1991-92, $30,000. e. Competitive Research Award, University of Texas MD Anderson Cancer Center: 1991-92, $3,500. f. American Cancer Society Research Fellowship: 1992-93, $3,600. CLINICAL ACTIVITIES: Dr. Moore spends more than 80 hours per week in patient care. He is actively part of the Catholic Ministries Winnebago-Omaha Nation in Nebraska. Dennis F. Moore, Jr. Curriculum Vitae – Page 4 TEACHING ACTIVITIES: Fall 1994 Oncologic Emergencies, Junior Tutorial Spring 1995 Oncologic Emergencies, Junior Tutorial - 3 sessions Fall 1995 Oncologic Emergencies, Junior Tutorial - 3 sessions Spring 1996 Oncologic Emergencies, Junior Tutorial - 3 sessions Fall 1996 Oncologic Emergencies, Junior Tutorial - 3 sessions Spring 1997 Oncologic Emergencies, Junior Tutorial - 3 sessions Fall 1997 Oncologic Emergencies, Junior Tutorial - 3 sessions Spring 1998 Oncologic Emergencies, Junior Tutorial - 3 sessions Spring 1995 4 months Resident Oncology Attending Fall 1995 2 months Resident Oncology Attending Spring 1996 5 months Resident Oncology Attending Fall 1996 4 months Resident Oncology Attending Spring 1997 3 months Resident Oncology Attending Fall 1997 3 months Resident Oncology Attending Spring 1998 5 months Resident Oncology Attending Fall 1998 4 months Resident Oncology Attending Spring 1997 7 lectures for Residents' Core Curriculum Series ADMINISTRATION: Dates Organization University of Kansas School of Medicine 1985 Multidisciplinary Cancer Committee Representative 1984-85 Medical Students' Assembly 1984-85 Blood Drive-Hepatavax Information Committee 1984-86 Jayhawker MD Yearbook Committee University of Kansas School of Medicine-Wichita 1986-87 Community Relations Committee Representative 1986-87 Research Committee University of Texas, M.D. Anderson Cancer Center 1992-93 Chief Fellow 1993-94 Lymphoma Section Clinic Liaison to Office of Managed Care 1993-94 Clinic Chief, Section of Lymphoma 1993-94 Committee on Managed Care 1993-94 Ad Hoc Committee on Marketing 1994 Alternate, Physician Advisor for Section of Bone Marrow Transplantation Dennis F. Moore, Jr. Curriculum Vitae – Page 5 PUBLISHED MANUSCRIPTS: 1. Moore D: The Importance of the Monocyte in Patients with Breast Cancer. 1984 Medical Student Research Training Program, KUMC 1984 Fall; 5: 296-323. 2. Pazdur R, Bready B, Moore DF Jr: Clinical Trials of Fluorouracil with Alpha-Interferon in Advanced Colorectal Carcinomas. Semin Oncol 1991 October; 18 (5 Suppl 7):67-70. 3. Pazdur R, Moore DF Jr, Bready B: The Modulation of Fluorouracil with Recombinant Alpha Interferon: The M.D. Anderson Clinical Trial. Semin Oncol 1991; 18 (Suppl 7):67-70. 4. Pazdur R, Moore D, Bready B: Modulation of Fluorouracil with Recombinant Alpha Interferon: M.D. Anderson Clinical Trial. Semin Oncol 1992; 19 (2 Suppl 3):176-179. 5. Moore DF Jr, Pazdur R, Daugherty K, Tarassoff P, Abbruzzesse JL: Phase II Study of Gemcitabine in Advanced Colorectal Carcinoma. Invest New Drugs 1992 Nov; 10(4):323-325. 6. Moore DF Jr, Pazdur R: Phase I Study of 5-Fluorouracil with Folinic Acid Combined with Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor. Am J Clin Oncol 1992 Dec; 15(6):464-466. 7. Pazdur R, Newman RA, Newman BM, Fuentes A, Benvenuto J, Bready B, Moore D, Jaiyesimi I, Vreeland F, Raber MN: Phase I Trial of Taxotere (RP 56976, NSC 628503): Five-day Schedule. J Natl Cancer Inst 1992; 84:1781-1788. 8. Moore D, Pazdur R: Systemic Therapies for Unresectable Primary Hepatic Tumors. J Surg Oncol 1993; 3(Suppl):112-114. 9. Moore DF Jr, Cabanillas F: What Constitutes a ‘Cure’ in Lymphoma? Leuk Lymphoma 1993; 11(3-4):161-163. 10. Moore DL Jr, Sears DA: Pica, Iron Deficiency, and the Medical History. Am J Med 1994; 97:390-393. 11. Moore DF, Pazdur R, Abbruzzese JL, Ajani JA, Dubovsky DW, Wade JL 3rd, Belt RJ, Mangold C, Bready B, Winn RJ: Phase II Trial of Edatrexate in Patients with Advanced Pancreatic Adenocarcinoma. Ann Oncol 1994 Mar; 5(3):286-287. 12. Pazdur R, Moore DF, Bready B, Giannone L, Maldonado A, Lin YG, Fueger RH, Winn RJ, Levin B: Phase II Trial of Edatrexate in Patients with Advanced Hepatocellular Carcinoma. Ann Oncol 1994 Sept; 5(7):646-648. 13. Moore DF Jr, Pazdur R, Abbruzzese JL: A Phase II Trial of Intravenous Melphalan in Advanced Colorectal Carcinoma. Invest New Drugs 1994; 12:133-136. 14. Moore DF, Kalvakolanu DV, Lippman SM, Kavanagh JJ, Hong WK, Borden EC, Paredes-Espinoza M, Krakoff IH: Retinoic Acid and Interferon in Human Cancer: Mechanistic and Clinical Studies. Semin Hematol 1994; 31(Suppl 5):31-37. 15. Romaguera JE, Rodriguez MA, Hagemeister FB, McLaughlin P, Swan F, Moore DF Jr, Sarris AH, Younes A, Hill D, Cabanillas F: A Phase II Trial of Oral Etoposide with Mitoxantrone and Ifosfamide/Mesna Consolidated with Intravenous